$BURUD NUBURU Issues Shareholder Letter on Strategic

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
81
$BURUD NUBURU Issues Shareholder Letter on Strategic Progress and NYSE American Appeal

Executive Chairman and Co-Chief Executive Officer Alessandro Zamboni discusses split-adjusted OTC trading, Tekne closing progress and execution of NUBURU’s dual-use Defense & Security platform

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (OTC Pink: BURUD) ("NUBURU" or the "Company" , a next-generation dual-use Defense & Security integrated platform company, today issued the following letter to shareholders from Alessandro Zamboni, Executive Chairman and Co-Chief Executive Officer.

Dear Fellow Shareholders,

NUBURU common stock is expected to begin trading today on a split-adjusted basis on the OTC Pink Market under the temporary symbol “BURUD,” following the 1-for-40 reverse stock split that became effective at 4:30 p.m. Eastern Time on September 1, 2026. The “D” suffix is expected to remain for 20 business days, after which the common stock is expected to resume trading on the OTC Pink Market under its base symbol, “BURU.” The reverse split is a mechanical change: it reduces the number of shares outstanding and proportionately adjusts the per-share reference price, while the market determines the trading price thereafter. Subject to the fractional-share treatment previously disclosed, it does not by itself change a shareholder’s proportional ownership or create economic value.

The reverse split was undertaken to address price-related considerations in the pending NYSE American appeal; it does not ensure compliance or resumption of trading. We believe shareholder value must come from execution: completing the proposed Tekne transaction, integrating complementary capabilities into one platform, converting opportunities into contracts and cash, and strengthening NUBURU’s capital structure.

NYSE American Process

NUBURU’s common stock remains listed on NYSE American under the symbol “BURU” pending completion of the appeal process, although trading on NYSE American remains suspended. The Company is in active dialogue with NYSE Regulation regarding the path to a potential resumption of trading. Any resumption remains subject to NYSE Regulation’s determination and completion of applicable corporate-action notice procedures. No decision has been made, NYSE Regulation has not provided the Company with a specific sustained post-split trading-price threshold or duration for a potential resumption of trading, and there can be no assurance whether or when trading on NYSE American will resume. We will report material developments as they occur.

Tekne: Closing Progress and Industrial Scale

As detailed in our September 1, 2026 release, NUBURU and the other parties are advancing the remaining steps toward the Company’s proposed acquisition of a 70% controlling interest in Tekne S.p.A. following the Italian Government’s Golden Power authorization on August 5, 2026. Based on current progress, NUBURU expects closing during the first half of October 2026, subject to completion of the remaining closing actions.

That release also reported Tekne management’s preliminary, unaudited review of its customer order portfolio, which indicated approximately $135.4 million in adjusted active remaining order value. That figure is management-derived, represents 100% of Tekne, remains subject to NUBURU’s customary closing verification, is not a measure defined under U.S. GAAP and does not represent recognized revenue, guaranteed future revenue, cash collections or financial guidance. It nonetheless provides a measurable operating benchmark against which shareholders can assess conversion into revenue and cash.

Building One Scalable Platform

Upon closing, Tekne is expected to add industrial depth in special vehicles, defense mobility, electronic systems, EW/CEMA and mission-package integration. NUBURU Defense Italy S.r.l. (“NDI”) is intended to coordinate the Group’s Italian activities and serve as an integration and governance hub, and NUBURU has initiated recruitment for a Chief Platform Officer to lead the common technical roadmap, architecture and cross-company productization. Within NDI, the planned Platform Integration and Software Factory, or “Platform Factory,” would be an integration and productization function rather than a separate manufacturing facility.

Our objective is a repeatable, multi-year model combining software licenses and subscriptions; hardware support, maintenance and upgrades; and integration, engineering and lifecycle services. These are strategic objectives, not contracted revenue or financial guidance.

Persistent Readiness and Strategic Alignment

Security requirements increasingly extend across peacetime, crisis and conflict, requiring persistent situational awareness, resilient communications, operational continuity and rapid adaptation. Allied defense and security investment in the United States and Europe is rising against that backdrop, and the August 2026 U.S. National Security Science and Technology Strategy identifies advanced manufacturing and materials, artificial intelligence and autonomy, communications and networking, directed energy, information management and cybersecurity, sensing and signature management, and space technologies among its priority areas. NUBURU believes its dual-use, multi-layer and multi-domain roadmap is directionally aligned with several of these themes. This is the Company’s own assessment and does not constitute government endorsement, qualification, an award, an order or a funding commitment, and our opportunity depends in each case on customer priorities, procurement, competition, funding and execution.

What Shareholders Should Measure

Tekne — closing the proposed transaction, implementing governance, and reporting disciplined conversion of orders into revenue and cash;

Platform execution — forming and operationalizing NDI, recruiting the Chief Platform Officer, advancing the Platform Factory and securing customer validation and contractual awards; and

Financial and capital-markets discipline — liquidity, capital allocation, dilution management and transparent updates regarding the NYSE American appeal.

Thank you for your patience and engagement. We believe NUBURU is assembling a strategically relevant platform as defense, infrastructure and digital-resilience needs converge. We also know that belief does not create value. We ask to be evaluated by milestones, contracts, revenue, cash and disciplined delivery — not by the arithmetic of a reverse split or a single trading day.

Sincerely,

Alessandro Zamboni

Executive Chairman and Co-Chief Executive Officer

About NUBURU, Inc.

NUBURU, Inc. (OTC Pink: BURUD) is a next-generation dual-use Defense & Security integrated platform company developing software-orchestrated, hardware-enabled capabilities for defense and security, critical infrastructure and digital-resilience markets. Its strategy includes directed-energy and non-kinetic effects, EW/CEMA, defense mobility, operational-resilience software and advanced deployable manufacturing. Following the temporary 20-business-day post-split period, the Company’s common stock is expected to resume trading on the OTC Pink Market under the symbol “BURU.” For more information, visit https://ir.nuburu.net/corporate-profile/default.aspx.

Forward-Looking Statements

This shareholder letter contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the commencement of split-adjusted OTC trading, the temporary and post-transition trading symbols and the reverse stock split; the NYSE American appeal, review process and possible resumption of trading; the timing and completion of the Tekne transaction; support provided to Tekne; Tekne’s order portfolio and conversion to revenue or cash; NDI, the Chief Platform Officer and Platform Factory; platform integration, customer adoption and potential recurring or lifecycle revenue; market opportunities; and U.S., EU, NATO and allied priorities.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, including delays or changes in market processing or the ticker-symbol transition; OTC-market liquidity and volatility; a post-split price decline or failure of the reverse split to achieve its purposes; delay or an adverse NYSE American outcome, including failure to satisfy NYSE Regulation or complete required procedures; delay or failure to close the Tekne transaction; changes in funding or consideration and the recoverability or treatment of support provided to Tekne; the preliminary, unaudited and non-U.S.-GAAP nature of Tekne information; differences among order measures; order modification, delay, cancellation, customer acceptance and collection risks; inability to form, staff or operationalize NDI or the Platform Factory; failure to recruit leadership, validate technology, win contracts or generate recurring revenue; government-procurement, competition, cybersecurity, supply-chain, export-control and regulatory risks; the possibility that allied defense initiatives do not produce eligible opportunities or awards; operating losses, negative cash flow, financing needs and dilution; and other risks in NUBURU’s SEC filings. Readers should not place undue reliance on forward-looking statements, which speak only as of their date. NUBURU undertakes no obligation to update them except as required by law. This letter is not investment advice, an offer to sell or a solicitation of an offer to buy securities.

https://www.businesswire.com/news/home/202609...n-Appeal 
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SHOEBOX PureTest Wins 2026 Award for Audiometry Innovation

Updated Category News Views 4

Breaking New Ground in Hearing Conservation This time, we're looking at SHOEBOX PureTest snagging the 2026 Hearing Technology Innovator Award. It marks yet another feather in their cap, standing tall in the Equipment, Audiometry category. You know, for those of us knee-deep in the stock game—and I mean neck-deep in financial stakes—spotting a company thriving through...

Continue Reading
OTconnect on Apple Watch: A New Fitness Era Dawns

Updated Category News Views 6

What’s Orangetheory Up To Now? Ah, fitness gadgets, where everyone’s seemingly got a scheme brewing. This time it's Orangetheory (OTF), turning your Apple Watch into your new best gym buddy. October 22, 2026, marks the launch of OTconnect for Apple Watch, offering a slick way for enthusiasts to tune into their own sweat metrics. If you’re already an Apple Watch...

Continue Reading
AceMyNursingExams Debuts Versatile Nursing Prep Platform

Updated Category News Views 4

A Digital Lifeline for Nursing Students Nursing students are buried in responsibilities: lectures, clinical rotations, and sometimes even a job to fund the whole marathon. And just when they think they’ve got it handled, boom, a mountain of exams rises up in front of them. AceMyNursingExams gets this, rolling out an online exam prep platform to keep these future...

Continue Reading
MLS Org's Sue Compass to Safeguard Fair Listing Access

Updated Category News Views 5

Real Estate Clash: MLS vs. Compass Imagine flipping on the TV to see a legal showdown brewing in the real estate world — you've got six heavy-hitter MLSs facing off against Compass, Inc. Yeah, we're talking a legal slugfest here, folks, as these MLSs rally to keep the playing field level for over 120,000 agents across the country. They're not messing around, bringing a...

Continue Reading
Carrier Drops $600M on U.S. Manufacturing Boost

Updated Category News Views 7

A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...

Continue Reading
College Athletics Needs a New Business Revolution

Updated Category News Views 3

Wake Up Call for College Athletics Here's a heads-up—college sports aren't just about cheering fans and game-day jerseys anymore. It's high time universities start thinking of athletics as businesses, blending the thrill of game day with the realities of financial statements. Michael Schreiber rang this bell loud and clear on the 'Disruption Interruption' podcast,...

Continue Reading
Oak View Group Partners with Payactiv for Employee Benefits

Updated Category News Views 9

Bringing Financial Flexibility to Venue Employees Oak View Group (OVG) has taken a bold step toward enhancing the financial lives of its workforce. They’ve teamed up with Payactiv, the trailblazer in Earned Wage Access (EWA), to deliver a more flexible way for their employees to access funds they've already earned. This move stretches across more than 40 locations...

Continue Reading
ImmVira's Bladder Cancer Trials: Promising Data Revealed

Updated Category News Views 0

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Continue Reading
Lennox-Gastaut Syndrome: Unseen Struggles and Hope Ahead

Updated Category News Views 4

Asking the World to See LGS Life throws curveballs, but Lennox-Gastaut Syndrome (LGS) comes barreling down like a freight train in the quiet. It's a rare form of epilepsy that sows chaos in young lives with relentless seizures, leaving families in a fog of uncertainty and heartbreak for years. On International LGS Awareness Day™, November 1, families and advocates are...

Continue Reading
Ping An Good Doctor Grows 35%: AI's Expanding Role

Updated Category News Views 2

Ping An Good Doctor's Noteworthy Financial Uptick Stop me if you've heard this one: a hefty hike in numbers that make investors straighten up a bit. Ping An Good Doctor did just that, reporting a 35% spark in net profit as the books closed up till September 2026. In a landscape where many health-tech firms merely tread water, these guys rode a wave of RMB 0.25 billion in...

Continue Reading

Top 5 Most Recently Viewed Articles

How Nasuni Helps Retail Giants Prepare for the Holiday Rush

Updated Category News Views 35

Nasuni Empowers Major Brands for Holiday Success Household brands are continually enhancing their competitiveness, driving customer growth, and boosting productivity with Nasuni's cutting-edge hybrid cloud solutions. As the holiday season approaches, the demands on retailers increase significantly. Nasuni, an enterprise data platform known for its robust capabilities in...

Continue Reading
JDE Peet’s Grants Shares and Awards to Incentive Plan Participants

Updated Category News Views 192

JDE Peet’s Employee Incentive Plans: Recent Grants and Transfers JDE Peet’s N.V. (EURONEXT: JDEP) has made significant strides in its approach to employee incentives, emphasizing its dedication to valuing its workforce. In a recent announcement, the company outlined its actions regarding share grants as part of its ongoing employee incentive plans. These initiatives...

Continue Reading
Liongard Appoints Brook Lee as VP for Community Growth

Updated Category News Views 329

Liongard Appoints Brook Lee as VP to Enhance MSP Engagement Liongard, a leading name in Attack Surface Management catering to Managed Service Providers (MSPs) and IT Service Providers, is excited to announce the appointment of Brook Lee as its new Vice President of Community and Channel. With more than 15 years of experience within the MSP industry, Brook brings a wealth...

Continue Reading
Celebrating Dr. Rachel L. Ivory's Influence in Education

Updated Category News Views 174

Honoring Dr. Rachel L. Ivory for Her Educational Contributions Featured prominently as a Pinnacle Professional Member, Dr. Rachel L. Ivory stands out for her substantial contributions to the fields of education and literature. Her dedication has led her to be recognized by many for her impactful work, especially in leadership training, publishing, and community...

Continue Reading
Zenocutuzumab Trial Yields Promising Results for Cancer

Updated Category News Views 9

Results Revealed: A Game Changer in Cholangiocarcinoma Treatment Zenocutuzumab is stirring the pot in cancer treatment with some potentially ground-breaking results recently unveiled. Partner Therapeutics, a biotech player with skin in the oncology game, has revealed results from the eNRGy trial. These findings have not only turned heads but also led to U.S. FDA approval...

Continue Reading